Baker Bros. Advisors LP Replimune Group, Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 10,045,336 shares of REPL stock, worth $104 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
10,045,336
Previous 9,545,336
5.24%
Holding current value
$104 Million
Previous $78 Million
15.93%
% of portfolio
1.2%
Previous 0.99%
Shares
10 transactions
Others Institutions Holding REPL
# of Institutions
153Shares Held
70MCall Options Held
26.7KPut Options Held
28.6K-
Price T Rowe Associates Inc Baltimore, MD9.24MShares$95.8 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA5.56MShares$57.7 Million3.26% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$50.5 Million6.46% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$48.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$32.3 Million0.01% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $511M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...